Price Transparency: It’s in the Best Interest of Patients and Providers

February 25, 2020

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool

He and Sharon Howard, fellow HIT leader at Surescripts, sat down recently to talk about Surescripts Real-Time Prescription Benefit and how it helps deliver patient-specific prescription benefit and cost information into the e-prescribing workflow. Specifically, they shared their perspectives on how these tools benefit both providers and patients, which physicians can adopt these tools into their practices and how patients should feel empowered to have the prescription cost conversation with their healthcare provider.

“When I was a practicing physician, I just thought about the best clinical choice for the patient. Non-adherence and cost weren’t on my mind,” Andrew explained.

My, how times have changed.

“I was at an industry event and had the opportunity to hear a physician tell a story that really hit home,” Sharon shared. She went on to recount that the physician’s patient came into the office and, though she’d been on a medication for quite some time, lab results indicated that adherence could be an issue. After some prodding, the patient apologized and broke down in tears, saying, “I can’t afford my medication so I’ve been cutting my pills in half to make them last longer.”

While these scenarios are all too common in healthcare today, Surescripts is working hard to make them few and far between.

Sharon and Andrew also discussed how price transparency tools like Real-Time Prescription Benefit can help reduce provider burnout. “This technology is making life better by removing administrative burden and eliminating rework,” explained Andrew.

“As costs of medication increase, so does the need for tools like this,” Andrew said.

Though adoption of technology can be challenging, he goes on to say that, in order to make it easier, there are three things Surescripts takes into consideration during product development.

Check out this video to discover what those three things are.

If you’re interested in learning more about our work to advance and deliver price transparency at the point of care, check out our 2019 Impact Report: Prescription Price Transparency. And follow us on Facebook to get all the details on our next Facebook Premiere video.

Related Articles

June 24, 2020

Pharmacists Can Now Sing a New Tune When Patients Ask About Cost

Thanks to Surescripts new Real-Time Prescription Benefit tool, pharmacists can finally address prescription cost concerns with access to patient-specific benefit information, out-of-pocket prescription costs, and therapeutic alternatives at the point of dispensing.

June 11, 2020

A Future Where Price Transparency is the Norm

Luis Rodriguez, Chief Executive Officer of Keycentrix Inc., sat down with Surescripts to talk about the value pharmacists add beyond putting pills in a bottle, and a future state of healthcare where price transparency is the standard and patients don’t have to be financially successful to stay well.  Read more...
June 08, 2020

Right Around the Corner: 2021 CMS Rule Requiring Real Time Benefit Tools

Beginning in January 2021–which is just six months from now—a new Centers for Medicare & Medicaid Services (CMS) regulation will require that Medicare Part D health plans implement real-time benefit tools. Here’s what you need to know.